Paul England and Anja Lunze discuss the UK and German approach to the infringement of second medical use patents with regard to recent case law.
A legal toolkit for life sciences companies and their investors providing access to information on:
We review the proposed new EU Regulations for the regulation of medical devices and in vitro diagnostic medical devices in Europe and the outstanding issues and complexity surrounding these...read more
This article reviews the CJEU's decision in the Forsgren case which discusses whether an SPC can be granted for a protein in a conjugated form when only the protein per se is patent protected...read more
Receive our monthly newsletter keeping you updated on recent developments and events in the Life Sciences sector...